ITLN1 and esophageal squamous cell carcinoma: Although no functional experiments were conducted on ITLN1, the authors noted its known anti-inflammatory actions—particularly its ability to dampen macrophage NF-κB signaling—which fits the study’s broader finding that high-risk ESCC tumors contain fewer B-cells and NK-cells and a more immunosuppressive micro- environment.